Shares of West Pharmaceutical Services (WST) Sees Large Outflow of Money

West Pharmaceutical Services (WST) : Money flow in the West Pharmaceutical Services (WST) stock was negative (0.61 million) on Wednesday, which shows that the investors used the strength in the stock price to reduce their holdings. The total traded value on upticks was $1.06 million, compared to $1.66 million on downticks. The total uptick to downtick ratio was 0.63, indicating the underlying weakness in the stock. Even in block trades, money flow was negative ($1.24 million), indicating selling on the strength. Downtick transaction value in block trades amounted to $1.24 million, indicating persistent selling. West Pharmaceutical Services (WST) traded $1.39 higher at $78.83 gaining 1.79% over the previous days close.


West Pharmaceutical Services (NYSE:WST): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $78.23 and $77.93 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $78.90. The buying momentum continued till the end and the stock did not give up its gains. It closed at $78.48, notching a gain of 1.34% for the day. The total traded volume was 344,193 . The stock had closed at $77.44 on the previous day.

The stock has recorded a 20-day Moving Average of 3.31% and the 50-Day Moving Average is 5.03%. In a related news, The Securities and Exchange Commission has divulged that Malone Daniel, officer (Vice President & Controller) of West Pharmaceutical Services Inc, had unloaded 3,950 shares at an average price of $74.95 in a transaction dated on June 2, 2016. The total value of the transaction was worth $296,053.

West Pharmaceutical Services, Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Companys products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services. The Companys customers include producers of pharmaceuticals, biologics, medical devices and personal care products. The Companys reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.